日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

XIST expression and hypermethylation of the X chromosome in males with systemic lupus erythematosus

系统性红斑狼疮男性患者中XIST表达和X染色体高甲基化

Masson, Helen O; Crawford, Jonathan D; Gemperline, David C; Scherschel, James E; Rocha, Guilherme G V; Preuss, Christoph; Wulur, Isabella H; Linnik, Matthew D; Higgs, Richard E; Dow, Ernst R

XIST expression and hypermethylation of the X chromosome in males with systemic lupus erythematosus

系统性红斑狼疮男性患者中XIST表达和X染色体高甲基化

Wagenaar, Carlijn A; van de Put, Marieke; Bisschops, Michelle; Walrabenstein, Wendy; de Jonge, Catharina S; Herrema, Hilde; van Schaardenburg, Dirkjan; Masson, Helen O; Crawford, Jonathan D; Gemperline, David C; Scherschel, James E; Rocha, Guilherme G V; Preuss, Christoph; Wulur, Isabella H; Linnik, Matthew D; Higgs, Richard E; Dow, Ernst R

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

巴瑞替尼的作用机制及活动性系统性红斑狼疮患者的生物标志物和关键免疫通路鉴定

Dörner, Thomas; Tanaka, Yoshiya; Dow, Ernst R; Koch, Alisa E; Silk, Maria; Ross Terres, Jorge A; Sims, Jonathan T; Sun, Zhe; de la Torre, Inmaculada; Petri, Michelle

Prediction and analysis of functional RNA structures within the integrative genomics viewer

在整合基因组浏览器内预测和分析功能性RNA结构

Rouse, Warren B; Andrews, Ryan J; Booher, Nicholas J; Wang, Jibo; Woodman, Michael E; Dow, Ernst R; Jessop, Theodore C; Moss, Walter N

The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis.

Janus激酶1/2抑制剂巴瑞替尼可降低中重度类风湿性关节炎患者的关节破坏生物标志物

Thudium Christian S, Bay-Jensen Anne C, Cahya Suntara, Dow Ernst R, Karsdal Morten A, Koch Alisa E, Zhang Wenling, Benschop Robert J

A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus

贝叶斯基因网络揭示了系统性红斑狼疮中JAK-STAT通路的关键信息

Li, Yupeng; Higgs, Richard E; Hoffman, Robert W; Dow, Ernst R; Liu, Xiong; Petri, Michelle; Wallace, Daniel J; Dörner, Thomas; Eastwood, Brian J; Miller, Bradley B; Liu, Yushi

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab

来自两项 III 期临床试验的 BAFF 阻断剂 Tabalumab 治疗系统性红斑狼疮患者的基因表达和药效学变化

Hoffman, Robert W; Merrill, Joan T; Alarcón-Riquelme, Marta M E; Petri, Michelle; Dow, Ernst R; Nantz, Eric; Nisenbaum, Laura K; Schroeder, Krista M; Komocsar, Wendy J; Perumal, Narayanan B; Linnik, Matthew D; Airey, David C; Liu, Yushi; Rocha, Guilherme V; Higgs, Richard E